State Street’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
2019
Q3
$39K Hold
2019
Q2
$68K Sell
2019
Q1
$383K Buy
2018
Q4
$365K Buy
2018
Q3
$1.4M Buy
2018
Q2
$1.35M Buy
2018
Q1
$1.43M Buy
2017
Q4
$2.55M Buy